|
KMID : 1144320200520020281
|
|
감염과 화학요법
2020 Volume.52 No. 2 p.281 ~ p.304
|
|
|
Interim Guidelines on Antiviral Therapy for COVID-19
|
|
Kim Sun-Bean
Huh Kyung-Min
Heo Jung-Yeon
Joo Eun-Jeong
Kim Youn-Jeong
Choi Won-Suk
Kim Yae-Jean
Seo Yu-Bin
Yoon Young-Kyung
Ku Nam-Su
Jeong Su-Jin
Kim Sung-Han
Peck Kyong-Ran
Yeom Joon-Sup
|
|
|
Abstract
|
|
|
|
Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019, Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January 2020. As of April 16, 2020, 10635 confirmed cases have been reported, with 230 deaths in Korea. COVID-19 patients may be asymptomatic or show various clinical manifestations, including acute symptoms such as fever, fatigue, sore throat; pneumonia presenting as acute respiratory distress syndrome; and multiple organ failure. As COVID-19 has such varied clinical manifestations and case fatality rates, no standard antiviral therapy regimen has been established other than supportive therapy. In the present guideline, we aim to introduce potentially helpful antiviral and other drug therapies based on in vivo and in vitro research and clinical experiences from many countries.
|
|
|
KEYWORD
|
|
|
COVID-19, SARS-CoV-2, Antiviral, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|